Literature DB >> 34962627

Synergistic Effect of Whitlockite Scaffolds Combined with Alendronate to Promote Bone Regeneration.

Jiwoon Jeong1,2, Jung Hee Shim3,4, Bum Mo Koo2, Young Bin Choy1,5,6, Chan Yeong Heo7,8,9.   

Abstract

BACKGROUND: Due to the increasing aging of society, the number of patients suffering from senile diseases is increasing. Patients suffering from osteoporosis, which is a representative senile disease, take a long time to recover from fractures, and the resulting mortality rate is very high. Alendronate (Ald), which is widely used as a treatment for osteoporosis, alleviates osteoporosis by inhibiting osteoclasts. In addition, whitlockite (WH) promotes the osteogenic differentiation of bone cells and improves bone regeneration. Therefore, we intended to bring about a synergistic effect by using these substances together.
METHODS: In this study, a scaffold composed of gelatin/heparin was fabricated and applied to effectively use WH and Ald together. A scaffold was constructed using gelatin and heparin was used to effectively utilize the cations released from WH. In addition, it formed a porous structure for effective bone regeneration. In vitro and in vivo osteoclast inhibition, osteogenic differentiation, and bone regeneration were studied using the prepared scaffolds.
RESULTS: The inhibition of osteoclast was much higher when WH and Ald were applied in combination rather than individually. The highest level of osteogenic differentiation was observed when both substances were applied simultaneously. In addition, when applied to bone regeneration through the mouse calvarial defect model, combined treatment showed excellent bone regeneration.
CONCLUSION: Therefore, this study showed the synergistic effect of WH and Ald, and it is suggested that better bone regeneration is possible by applying this treatment to bones with fractures that are difficult to regenerate.
© 2021. The Korean Tissue Engineering and Regenerative Medicine Society.

Entities:  

Keywords:  Alendronate; Bone regeneration; Hydrogel scaffold; Whitlockite

Mesh:

Substances:

Year:  2021        PMID: 34962627      PMCID: PMC8782946          DOI: 10.1007/s13770-021-00416-2

Source DB:  PubMed          Journal:  Tissue Eng Regen Med        ISSN: 1738-2696            Impact factor:   4.169


  33 in total

1.  Biomimetic whitlockite inorganic nanoparticles-mediated in situ remodeling and rapid bone regeneration.

Authors:  Hwan D Kim; Hae Lin Jang; Hyo-Yong Ahn; Hye Kyoung Lee; Jungha Park; Eun-Seo Lee; Eunjee A Lee; Yong-Hoon Jeong; Do-Gyoon Kim; Ki Tae Nam; Nathaniel S Hwang
Journal:  Biomaterials       Date:  2016-10-11       Impact factor: 12.479

2.  In Vitro and In Vivo Evaluation of Whitlockite Biocompatibility: Comparative Study with Hydroxyapatite and β-Tricalcium Phosphate.

Authors:  Hae Lin Jang; Guang Bin Zheng; Jungha Park; Hwan D Kim; Hae-Ri Baek; Hye Kyoung Lee; Keunho Lee; Heung Nam Han; Choon-Ki Lee; Nathaniel S Hwang; Jae Hyup Lee; Ki Tae Nam
Journal:  Adv Healthc Mater       Date:  2015-05-12       Impact factor: 9.933

3.  Fall-induced injuries and deaths among older adults.

Authors:  P Kannus; J Parkkari; S Koskinen; S Niemi; M Palvanen; M Järvinen; I Vuori
Journal:  JAMA       Date:  1999-05-26       Impact factor: 56.272

4.  Revisiting whitlockite, the second most abundant biomineral in bone: nanocrystal synthesis in physiologically relevant conditions and biocompatibility evaluation.

Authors:  Hae Lin Jang; Kyoungsuk Jin; Jaehun Lee; Younghye Kim; Seung Hoon Nahm; Kug Sun Hong; Ki Tae Nam
Journal:  ACS Nano       Date:  2013-12-06       Impact factor: 15.881

5.  Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromal cells by alendronate via ERK and JNK activation.

Authors:  Lingjie Fu; Tingting Tang; Yanying Miao; Shuhong Zhang; Zhihu Qu; Kerong Dai
Journal:  Bone       Date:  2008-03-29       Impact factor: 4.398

6.  Osteoporosis: A Review of Treatment Options.

Authors:  Kristie N Tu; Janette D Lie; Chew King Victoria Wan; Madison Cameron; Alaina G Austel; Jenny K Nguyen; Kevin Van; Diana Hyun
Journal:  P T       Date:  2018-02

7.  Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis.

Authors:  Kenneth G Saag; Jeffrey Petersen; Maria Luisa Brandi; Andrew C Karaplis; Mattias Lorentzon; Thierry Thomas; Judy Maddox; Michelle Fan; Paul D Meisner; Andreas Grauer
Journal:  N Engl J Med       Date:  2017-09-11       Impact factor: 91.245

8.  Rational design of gelatin/nanohydroxyapatite cryogel scaffolds for bone regeneration by introducing chemical and physical cues to enhance osteogenesis of bone marrow mesenchymal stem cells.

Authors:  K T Shalumon; Han-Tsung Liao; Chang-Yi Kuo; Chak-Bor Wong; Chien-Ju Li; Mini P A; Jyh-Ping Chen
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2019-06-05       Impact factor: 7.328

9.  Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures.

Authors:  Kristine E Ensrud; Susan K Ewing; Brent C Taylor; Howard A Fink; Katie L Stone; Jane A Cauley; J Kathleen Tracy; Marc C Hochberg; Nicolas Rodondi; Peggy M Cawthon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-07       Impact factor: 6.053

10.  Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.

Authors:  Dana Bliuc; Nguyen D Nguyen; Vivienne E Milch; Tuan V Nguyen; John A Eisman; Jacqueline R Center
Journal:  JAMA       Date:  2009-02-04       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.